help button home button Am J Pathol Epitomics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geisbert, T. W.
Right arrow Articles by Hensley, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geisbert, T. W.
Right arrow Articles by Hensley, L. E.
(American Journal of Pathology. 2003;163:2371-2382.)
© 2003 American Society for Investigative Pathology

Pathogenesis of Ebola Hemorrhagic Fever in Primate Models

Evidence that Hemorrhage Is Not a Direct Effect of Virus-Induced Cytolysis of Endothelial Cells

Thomas W. Geisbert*, Howard A. Young{dagger}, Peter B. Jahrling*, Kelly J. Davis*, Tom Larsen*, Elliott Kagan{ddagger} and Lisa E. Hensley*

From the United States Army Medical Institute of Infectious Diseases,* Fort Detrick; the Laboratory of Experimental Immunology,{dagger} Center for Cancer Research, National Cancer Institute-Frederick, Frederick; and the Uniformed Services University of the Health Sciences,{ddagger} Bethesda, Maryland

Ebola virus (EBOV) infection causes a severe and often fatal hemorrhagic disease in humans and nonhuman primates. Whether infection of endothelial cells is central to the pathogenesis of EBOV hemorrhagic fever (HF) remains unknown. To clarify the role of endothelial cells in EBOV HF, we examined tissues of 21 EBOV-infected cynomolgus monkeys throughout time, and also evaluated EBOV infection of primary human umbilical vein endothelial cells and primary human lung-derived microvascular endothelial cells in vitro. Results showed that endothelial cells were not early cellular targets of EBOV in vivo, as viral replication was not consistently observed until day 5 after infection, a full day after the onset of disseminated intravascular coagulation. Moreover, the endothelium remained relatively intact even at terminal stages of disease. Although human umbilical vein endothelial cells and human lung-derived microvascular endothelial cells were highly permissive to EBOV replication, significant cytopathic effects were not observed. Analysis of host cell gene response at 24 to 144 hours after infection showed some evidence of endothelial cell activation, but changes were unremarkable considering the extent of viral replication. Together, these data suggest that coagulation abnormalities associated with EBOV HF are not the direct result of EBOV-induced cytolysis of endothelial cells, and are likely triggered by immune-mediated mechanisms.





This article has been cited by other articles:


Home page
BloodHome page
A. Shibamiya, K. Hersemeyer, T. Schmidt Woll, D. Sedding, J.-M. Daniel, S. Bauer, T. Koyama, K. T. Preissner, and S. M. Kanse
A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells
Blood, January 15, 2009; 113(3): 714 - 722.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y.-T. Yen, H.-C. Chen, Y.-D. Lin, C.-C. Shieh, and B. A. Wu-Hsieh
Enhancement by Tumor Necrosis Factor Alpha of Dengue Virus-Induced Endothelial Cell Production of Reactive Nitrogen and Oxygen Species Is Key to Hemorrhage Development
J. Virol., December 15, 2008; 82(24): 12312 - 12324.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. B. Bradfute, K. L. Warfield, and S. Bavari
Functional CD8+ T Cell Responses in Lethal Ebola Virus Infection
J. Immunol., March 15, 2008; 180(6): 4058 - 4066.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Bukreyev, P. E. Rollin, M. K. Tate, L. Yang, S. R. Zaki, W.-J. Shieh, B. R. Murphy, P. L. Collins, and A. Sanchez
Successful Topical Respiratory Tract Immunization of Primates against Ebola Virus
J. Virol., June 15, 2007; 81(12): 6379 - 6388.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Neumann, T. W. Geisbert, H. Ebihara, J. B. Geisbert, K. M. Daddario-DiCaprio, H. Feldmann, and Y. Kawaoka
Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Critical for Ebola Virus Replication in Nonhuman Primates
J. Virol., March 15, 2007; 81(6): 2995 - 2998.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A.-M. Connolly-Andersen, K.-E. Magnusson, and A. Mirazimi
Basolateral Entry and Release of Crimean-Congo Hemorrhagic Fever Virus in Polarized MDCK-1 Cells
J. Virol., March 1, 2007; 81(5): 2158 - 2164.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Srikiatkhachorn, C. Ajariyakhajorn, T. P. Endy, S. Kalayanarooj, D. H. Libraty, S. Green, F. A. Ennis, and A. L. Rothman
Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever
J. Virol., February 15, 2007; 81(4): 1592 - 1600.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Shimojima, A. Takada, H. Ebihara, G. Neumann, K. Fujioka, T. Irimura, S. Jones, H. Feldmann, and Y. Kawaoka
Tyro3 family-mediated cell entry of ebola and marburg viruses.
J. Virol., October 1, 2006; 80(20): 10109 - 10116.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Marzi, A. Akhavan, G. Simmons, T. Gramberg, H. Hofmann, P. Bates, V. R. Lingappa, and S. Pohlmann
The Signal Peptide of the Ebolavirus Glycoprotein Influences Interaction with the Cellular Lectins DC-SIGN and DC-SIGNR.
J. Virol., July 1, 2006; 80(13): 6305 - 6317.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
N. Alazard-Dany, V. Volchkova, O. Reynard, C. Carbonnelle, O. Dolnik, M. Ottmann, A. Khromykh, and V. E. Volchkov
Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level.
J. Gen. Virol., May 1, 2006; 87(Pt 5): 1247 - 1257.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. C. Kash, E. Muhlberger, V. Carter, M. Grosch, O. Perwitasari, S. C. Proll, M. J. Thomas, F. Weber, H.-D. Klenk, and M. G. Katze
Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence
J. Virol., March 15, 2006; 80(6): 3009 - 3020.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Bukreyev, L. Yang, S. R. Zaki, W.-J. Shieh, P. E. Rollin, B. R. Murphy, P. L. Collins, and A. Sanchez
A Single Intranasal Inoculation with a Paramyxovirus-Vectored Vaccine Protects Guinea Pigs against a Lethal-Dose Ebola Virus Challenge
J. Virol., March 1, 2006; 80(5): 2267 - 2279.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. M. Wahl-Jensen, T. A. Afanasieva, J. Seebach, U. Stroher, H. Feldmann, and H.-J. Schnittler
Effects of Ebola Virus Glycoproteins on Endothelial Cell Activation and Barrier Function
J. Virol., August 15, 2005; 79(16): 10442 - 10450.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. B. Jahrling, L. E. Hensley, M. J. Martinez, J. W. LeDuc, K. H. Rubins, D. A. Relman, and J. W. Huggins
From The Cover: Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox
PNAS, October 19, 2004; 101(42): 15196 - 15200.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. W. Geisbert, L. E. Hensley, T. Larsen, H. A. Young, D. S. Reed, J. B. Geisbert, D. P. Scott, E. Kagan, P. B. Jahrling, and K. J. Davis
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques: Evidence that Dendritic Cells Are Early and Sustained Targets of Infection
Am. J. Pathol., December 1, 2003; 163(6): 2347 - 2370.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.